Lung Cancer
A Phase 2 Study of EIK1001 in Combination with Pembrolizumab and Chemotherapy in Patients with Stage 4 Non-Small Cell Lung Cancer (EIK1001-005)
- Details
ClinicalTrials.gov ID:
NCT06246110
Diagnosis Type:
NA
USOR Number:
- Address
,
P: